These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30775402)
1. Clinical Characteristics and Radiologic Features of Immunocompromised Patients With Pauci-Bacillary Pulmonary Tuberculosis Receiving Delayed Diagnosis and Treatment. Park JH; Choe J; Bae M; Choi S; Jung KH; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Jo KW; Shim TS; Kim MY; Kim SH Open Forum Infect Dis; 2019 Feb; 6(2):ofz002. PubMed ID: 30775402 [TBL] [Abstract][Full Text] [Related]
2. Clinical and radiologic characteristics of radiologically missed miliary tuberculosis. Choe J; Jung KH; Park JH; Kim SH; Kim MY Medicine (Baltimore); 2021 Feb; 100(8):e23833. PubMed ID: 33663042 [TBL] [Abstract][Full Text] [Related]
3. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis. Lee HN; Kim JI; Kim YH PLoS One; 2021; 16(5):e0250616. PubMed ID: 33939723 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734 [TBL] [Abstract][Full Text] [Related]
5. Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India. Singh UB; Pandey P; Mehta G; Bhatnagar AK; Mohan A; Goyal V; Ahuja V; Ramachandran R; Sachdeva KS; Samantaray JC PLoS One; 2016; 11(2):e0149258. PubMed ID: 26894283 [TBL] [Abstract][Full Text] [Related]
6. [A study of the value of three molecular diagnostic techniques in the diagnosis of tuberculosis]. Huang F; Dang L; Sun H; Yang H; Wu X Zhonghua Jie He He Hu Xi Za Zhi; 2015 Sep; 38(9):680-5. PubMed ID: 26703773 [TBL] [Abstract][Full Text] [Related]
7. Thoracoscopic pleural biopsy improves yield of Xpert MTB/RIF for diagnosis of pleural tuberculosis. Christopher DJ; Dinakaran S; Gupta R; James P; Isaac B; Thangakunam B Respirology; 2018 Jul; 23(7):714-717. PubMed ID: 29486527 [TBL] [Abstract][Full Text] [Related]
8. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF. Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890 [TBL] [Abstract][Full Text] [Related]
9. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China. Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292 [TBL] [Abstract][Full Text] [Related]
10. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study. Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619 [TBL] [Abstract][Full Text] [Related]
11. Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients. Lee JY; Lee HJ; Kim YK; Yu S; Jung J; Chong YP; Lee SO; Choi SH; Shim TS; Kim YS; Woo JH; Kim SH Antimicrob Agents Chemother; 2016 Jul; 60(7):4005-12. PubMed ID: 27090178 [TBL] [Abstract][Full Text] [Related]
12. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand. Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria. Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972 [TBL] [Abstract][Full Text] [Related]
14. Effective testing for pulmonary tuberculosis using Xpert MTB/RIF assay for stool specimens in immunocompetent Pakistani children. Hasan Z; Arif F; Shakoor S; Mehnaz A; Akber A; Kanji A; Ashraf M; Hasan R Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S8-S9. PubMed ID: 28043630 [TBL] [Abstract][Full Text] [Related]
15. Newer Diagnostic Tests and their Application in Pediatric TB. Wattal C; Raveendran R Indian J Pediatr; 2019 May; 86(5):441-447. PubMed ID: 30628039 [TBL] [Abstract][Full Text] [Related]
16. Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes. Pires MM; Pereira GR; Barbosa MS; Dias NJD; Secchi C; Hoff JS; Silva DR Lung; 2020 Dec; 198(6):985-989. PubMed ID: 33128653 [TBL] [Abstract][Full Text] [Related]
17. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation. Reither K; Manyama C; Clowes P; Rachow A; Mapamba D; Steiner A; Ross A; Mfinanga E; Sasamalo M; Nsubuga M; Aloi F; Cirillo D; Jugheli L; Lwilla F J Infect; 2015 Apr; 70(4):392-9. PubMed ID: 25312863 [TBL] [Abstract][Full Text] [Related]
18. A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns. Donkeng-Donfack VF; Tchatchueng-Mbougua JB; Abanda NN; Ongboulal SM; Djieugoue YJ; Kamdem Simo Y; Mekemnang Tchoupa M; Bekang Angui F; Kuate Kuate A; Mbassa V; Mvondo Abeng Belinga E; Eyangoh S BMC Infect Dis; 2022 Mar; 22(1):219. PubMed ID: 35246071 [TBL] [Abstract][Full Text] [Related]
19. Association of Radiological Findings with the Xpert MTB/RIF Test in Patients with Suspected Pulmonary Tuberculosis. Neto WOE; Pereira GR; Barbosa MS; Dias NJD; Silva DR Lung; 2018 Dec; 196(6):755-760. PubMed ID: 30178313 [TBL] [Abstract][Full Text] [Related]
20. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses. Kendall EA; Kamoga C; Kitonsa PJ; Nalutaaya A; Salvatore PP; Robsky K; Nakasolya O; Mukiibi J; Isooba D; Cattamanchi A; Kato-Maeda M; Katamba A; Dowdy DW PLoS One; 2019; 14(7):e0220251. PubMed ID: 31339935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]